Trastuzumab, but not pertuzumab, dysregulates HER2 signaling to mediate inhibition of autophagy and increase in reactive oxygen species production in human cardiomyocytes - Mohan, N; Shen, Y; Endo, Y; ElZarrad, M K; Wu, W J (Mol Cancer Ther, 2016)